During the past decade, Walter Mackenzie Health Sciences Centre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Walter Mackenzie Health Sciences Centre" #1 sponsor was "Mitsubishi Tanabe Pharma America Inc." with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Edge Therapeutics Inc" with 2 trials sponsored, "Otsuka America Pharmaceutical" with 2 trials sponsored and "University of Alberta" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Walter Mackenzie Health Sciences Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Hartford Hospital" with 1 trials as a collaborator and "Henry Ford Hospital" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Walter Mackenzie Health Sciences Centre" are "Ulcerative Colitis" (4 trials), "ALS" (3 trials), "Stroke" (3 trials), "Crohn's Disease" (2 trials) and "Subarachnoid Hemorrhage, Aneurysmal" (2 trials). Many other conditions were trialed in "Walter Mackenzie Health Sciences Centre" in a lesser frequency.

Most popular intervention types in "Walter Mackenzie Health Sciences Centre" are "Drug" (14 trials), "Device" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "MT-1186" (4 trials), "CP-690,550" (2 trials), "EG-1962 (nimodipine microparticles)" (2 trials) and "Enteral Nimodipine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Walter Mackenzie Health Sciences Centre" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Walter Mackenzie Health Sciences Centre". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Walter Mackenzie Health Sciences Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Walter Mackenzie Health Sciences Centre, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".